SLGI Asset Management Inc. Buys More Johnson & Johnson Shares in Latest 13F Filing

SLGI Asset Management Inc. Buys More Johnson & Johnson Shares in Latest 13F Filing

In its latest SEC 13F filing, SLGI Asset Management Inc. revealed a notable addition to its position in Johnson & Johnson (JNJ), a leader in the Medical Biology sector. The firm increased its holdings by 17,900 shares, bringing its total market value in JNJ to approximately $20.52 million. This move keeps Johnson & Johnson at 0.86% of SLGI's overall portfolio.

Deep Dive into the Trade

The recent purchase reflects SLGI Asset Management's confidence in the long-term prospects of Johnson & Johnson. Despite the increase in shares, the percentage allocation of JNJ in the portfolio remains unchanged at 0.86%, indicating a steady approach to managing exposure within the Medical Biology industry.

As of this filing, SLGI's ownership represents less than 0.01% of Johnson & Johnson's total outstanding shares, showcasing that while the firm is bullish on the stock, it remains a relatively small stakeholder in the company.

Why is SLGI Asset Management Buying Johnson & Johnson?

Johnson & Johnson is a global leader in healthcare, with a diversified portfolio spanning pharmaceuticals, medical devices, and consumer health products. The company's resilience and innovation in the Medical Biology space likely make it an attractive investment for institutional players like SLGI Asset Management. This addition could signal confidence in JNJ’s ability to navigate market challenges and deliver consistent returns.

Portfolio Impact

With JNJ now accounting for 0.86% of SLGI Asset Management's portfolio, this move underscores the firm's strategy to maintain a diversified allocation. The increase in shares aligns with a broader trend of institutional investors seeking stability and growth in the healthcare sector.

For more insights into SLGI Asset Management Inc.'s investment strategy, including its full real-time portfolio and historical 13F data, view SLGI Asset Management Inc.’s full portfolio here.